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Abstract
Background: Virus-like particles (VLP) have an increasing range of applications including vaccination, drug delivery,
diagnostics, gene therapy and nanotechnology. These developments require large quantities of particles that need
to be obtained in efficient and economic processes. Production of VLP in yeast is attractive, as it is a low-cost
protein producer able to assemble viral structural proteins into VLP. However, to date only single-layered VLP with
simple architecture have been produced in this system. In this work, the first steps required for the production of
rotavirus-like particles (RLP) in S. cerevisiae were implemented and improved, in order to obtain the recombinant
protein concentrations required for VLP assembly.
Results: The genes of the rotavirus structural proteins VP2, VP6 and VP7 were cloned in four Saccharomyces
cerevisiae strains using different plasmid and promoter combinations to express one or three proteins in the same
cell. Performance of the best constructs was evaluated in batch and fed-batch cultures using a complete synthetic
media supplemented with leucine, glutamate and succinate. The strain used had an important effect on
recombinant protein concentration, while the type of plasmid, centromeric (YCp) or episomal (YEp), did not affect
protein yields. Fed-batch culture of the PD.U-267 strain resulted in the highest concentration of rotavirus proteins.
Volumetric and specific productivities increased 28.5- and 11-fold, respectively, in comparison with batch cultures.
Expression of the three rotavirus proteins was confirmed by immunoblotting and RLP were detected using
transmission electron microscopy.
Conclusions: We present for the first time the use of yeast as a platform to express multilayered rotavirus-like
particles. The present study shows that the combined use of molecular and bioprocess tools allowed the
production of triple-layered rotavirus RLP. Production of VLP with complex architecture in yeasts could lead to the
development of new vaccine candidates with reduced restrictions by regulatory agencies, using the successful
experience with other yeast-based VLP vaccines commercialized worldwide.
Background
Virus-like particles (VLP) are obtained when viral struc-
tural proteins are produced in heterologous expression
systems in absence of viral genetic material. VLP assem-
ble without the action of non-structural viral proteins
and have the same architectural characteristics as native
viral particles. The current market demand of VLP is
primarily as products for vaccination [1], but other
applications include diagnostics, biomedicine, material
science and nanotechnology [2,3]. VLP have successfully
protected humans and animals from viral diseases [4],
inducing excellent humoral and cellular immune
responses [5,6]. To date, a few VLP-based vaccines are
currently used for human vaccination worldwide: hepati-
tis B and human papillomavirus vaccines are commer-
cialized by several pharmaceutical companies. Other
VLP-based vaccine candidates are in clinical trials or
undergoing preclinical evaluation, such as influenza
virus, parvovirus, Norwalk and various chimeric VLP
[7,8]. VLP have been expressed in different heterologous
systems, from bacteria and yeasts to the insect cell/bacu-
lovirus system (IC-BVS) and various mammalian cell
lines. Ease of expression, ability to scale up and cost of
production have made yeast the most popular VLP
expression system [9]. However, to date yeasts have only
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protein layer.
Saccharomyces cerevisiae, Hansenula polymorpha and
Pichia pastoris have been used to produce single-layered
VLP of different viruses composed of a single nucleo-
capsid protein or a chimeric protein assembled in one
layer [7,10]. The production of multilayered VLP in
yeast imposes various challenges. First, several recombi-
nant proteins need to be simultaneously produced in
each cell in conditions adequate for their self-assembly
into VLP. Second, the intracellular concentration of
each structural protein should be high enough to pro-
mote VLP assembly. Third, the intracellular environ-
ment should be adequate for assembly.
In this work, rotavirus-like particles (RLP) were used
as a model for multiple layer VLP production in yeast.
Rotavirus is the major etiological agent of gastroenteritis
in children and young animals [11,12]. Each year, rota-
virus causes the death of approximately 610,000 children
and 39% of hospitalizations for diarrhea worldwide [13].
Moreover, rotavirus is an important cause of economic
losses in animal production, including death, loss of
weight and treatment of affected animals [14,15]. RLP
represent an interesting alternative to traditional vac-
cines that are now in the market, as they are efficient
immunogens, cannot revert to infectious forms, do not
need to be inactivated, handling of potentially patho-
genic viruses is not needed, and new recombinant vac-
cines for new serotypes can be rapidly and easily
produced [8,9].
Rotavirus-like particles have been frequently expressed
in the insect cell-baculovirus expression system [8]. This
system has proven to be productive and versatile. How-
ever, insect cell culture requires high cost media and
baculovirus manipulation requires highly skilled person-
nel. In contrast, yeast expression systems are easy to
scale-up and highly productive.
RLP production requires the simultaneous expression
and assembly of three recombinant proteins, 120 mole-
cules of VP2 (inner layer), 780 molecules of VP6 (mid-
dle layer) and 780 molecules of the glycoprotein VP7
(outer layer), into triple-layered particles (tlRLP) [16]. In
this work, molecular strategies to simultaneously express
the three recombinant proteins in S. cerevisiae and
molecular and process strategies to increase their con-
centration in yeast cells were developed. To our knowl-
edge, this is the first time that double or triple-layered
VLP are produced in yeast cells.
Methods
Yeast strains and plasmids
Four Saccharomyces cerevisiae parental strains were
used in this work: CEN.PK113-5D, W303-1a, PD 83B.1d
and PJ69-4a. From these parental strains, 12 strains
were constructed (Table 1). The rotavirus VP2 gene was
obtained from the bovine rotavirus strain RF. To facili-
tate VP2 expression, the coding sequence for its first 92
amino acids, not necessary for VLP formation [17], was
eliminated, and the ribosome binding site (RBS)
sequence was optimized as previously described [18].
The new RBS sequence (TTCAAACAAA) was inserted
by PCR before the initial ATG codon. This truncated
VP2 is identified as ΔVP2 in Figure 1 and Table 1. The
VP6 gene was obtained from the NCDV rotavirus strain
and the VP7 gene from the MX002 strain [19]. All rota-
virus genes used in this work have a bovine origin, and
their compatibility was confirmed by their amino acid
sequence homology to rotavirus NCDV proteins using
BLAST (accession numbers: X14057, DQ870494,
DQ870496, X65940, M12394, and FJ217205). The three
genes were cloned in the pSP-GM2 plasmid, a variant of
the pSP-G2 plasmid, recently developed by Partow et al.
[20], for multiple gene expression. The cloning strategy
is presented in Figure 1. To compare the expression
levels in different plasmid types, the VP6 gene was also
cloned in the centromeric plasmid (pRS7) under the
PMA1 promoter. Yeast transformation was performed
as described previously [21]. Table 1 lists the plasmids
constructed and the strains used in this study.
Culture media
Batch cultures were performed in a complete synthetic
medium (CSM) without uracil. The medium contained
glucose 20 g/L, yeast nitrogen base (Sigma-Aldrich Inc.,
S t .L o u i s ,M O ,U S A )6 . 7g / La n dC S M- u r a0 . 7 7g / L
(Foremedium, Hunstanton, UK). Strains PJ.T-6 and W.
T-6 were cultured in CSM without tryptophan. Media
composition was improved using data from two two-
level factorial designs of experiments in shake flask cul-
tures, using VP6 and biomass concentration as response
variables (data not shown). Based on the obtained
results, culture medium was supplemented with leucine
1 . 8m M ,g l u t a m a t e2 0m Ma n ds u c c i n a t e5 0m M .p H
was adjusted to 5.0 with KOH 2 N before autoclaving.
Feeding medium for fed-batch cultures was 10 X CSM
without supplements.
Cultivation of recombinant yeast
All cultures were performed in triplicate in parallel 1L
bioreactors (DasGip, Jülich, Germany) with a working
volume of 0.7 L. pH was controlled at 5.0 with KOH
2N. The sparged air flow rate was 42 L/h (1 vvm). Car-
bon dioxide and oxygen concentrations in the outlet gas
were measured with a DasGip GA4 gas analyzer. Cul-
tures were inoculated to an initial OD600 of 0.01 with a
liquid preculture.
The initial volume in fed-batch cultures was 0.4 L.
Feeding followed an exponential rate and started when
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to 2.5 mM/h, which indicated glucose depletion. The
feeding profile of the culture is expressed as follows:
F = abx0V0ebt (1)
where:
a =
Ys/x
C
f
s − Cs
(2)
and F is the feeding flow rate; b, a feeding constant
(0.19 h
-1), x0 is the initial biomass concentration at the
end of the batch phase; Vo, the initial volume (0.4 L); t,
time; Ys/x, the substrate over biomass ratio (assumed to
be 6.06 g glucose/g DCW for all strains); C
f
s,t h es u b -
strate concentration in the feed (200 g glucose/L); and
Cs, the substrate concentration at time t.
Analytical methods
Dry cell weight was measured by filtration through a
0.45 μm pore-size nitrocellulose filters (Sartorious, Göt-
tingen, Germany) as previously described [22].
Glucose, glycerol, ethanol, pyruvate, succinate and
acetate concentrations were measured in culture super-
natants by HPLC (UltiMate
® 3000 Standard LC system,
Dionex, California, USA) using a HPX-87H Aminex
column (Biorad, Richmond, CA, USA) at 50°C with 5
mM H2SO4 as mobile phase at 0.6 mL/min.
Recombinant proteins were extracted from the cell
pellet using YeastBuster protein extraction buffer (EMD
Biosciences, Inc, Darmstadt, Germany) following the
manufacturer’s instructions. VP6 was quantified by
ELISA (ProSpecT, Oxoid, Cambridge, UK). VP2, VP6
and VP7 were detected by immunoblotting with mono-
clonal antibodies at different stages of purification.
Briefly, 200 μL of each sample were filtered through a
nitrocellulose membrane using a Bio-dot
® apparatus
(Biorad, Richmond, CA, USA). Membranes were
blocked with 5% non-fat dried milk in phosphate buf-
fered solution (PBS), incubated for 1 h with monoclonal
antibodies in PBS with 0.1% non-fat milk (3A8 for VP2,
255 for VP6 and IC3 for VP7, kindly provided by Drs.
Arias and López, IBt- UNAM, Mexico). All monoclonal
antibodies used bind conformational epitopes. There-
fore, non-denaturing conditions are required for detect-
ing rotavirus proteins with them. Membranes were
washed three times with PBS with 0.1% non-fat milk,
incubated for 1 h with a goat anti-mouse antibody con-
jugated with peroxidase (Jackson, Immunoresearch
laboratories, West Grove, PA, USA), and washed three
times. Peroxidase activity was detected by reaction with
Table 1 Yeasts and plasmids used in this study. Parental strains and their derivatives are shown
Strain Genotype Plasmid Plasmid description Reference
W303-1a MATa ade2-1 can1-100 ura3-1
leu2-3,112 his3-11,15 trp1-1
-
W.TLU-C pRS7, pRS2, pSal4 PPMA1, CEN6/ARSH4, TRP1
PPMA1,2μ, LEU2, PCUP1,2μ, URA3
This study
W.T-6
d pRS7VP6 PPMA1VP6, CEN6/ARSH4, TRP1 This study
CEN.PK.113-5D MATa SUC2 MAL2-8c ura3-52 - Peter Kotter
a
CEN.U-C pSP-GM2 PPGK1,P TEF1,2μ, URA3 This study
CEN.U-6
d pWR6 PPGK1,P TEF1VP6, 2 μ, URA3 This study
CEN-U-267
e pWR267 PPGK1ΔVP2, PTEF1VP6, PTEF1VP7 2 μ, URA3 This study
PD 83B.1d
b MATa LEU ura31 TRP HIS
ADE can1100 GAL SUC2
- Stefan Hohmann
c
PD.U-C pSP-GM2 PPGK1,P TEF1,2μ, URA3 This study
PD.U-6
d pWR6 PPGK1,P TEF1VP6, 2 μ, URA3 This study
PD.U-267
e pWR267 PPGK1ΔVP2, PTEF1VP6, PTEF1VP7 2 μ, URA3 This study
PJ69-4a MATa trp1-901, leu2-3,112,
ura3-52, his 3-200, gal4D
gal80D
-
PJ.U-C pSP-GM2 PPGK1,P TEF1,2μ, URA3 This study
PJ.T-6
d pRS7VP6 PPMA1VP6, CEN6/ARSH4, TRP1 This study
PJ.U-6
d pWR6 PPGK1,P TEF1VP6, 2 μ, URA3 This study
PJ.U-267
e pWR267 PPGK1ΔVP2, PTEF1VP6, PTEF1VP7 2 μ, URA3 This study
a. J. W. Goethe Universität, Germany
b. Strain with W303-1a background
c. Gothenburg University, Sweden
d. Contains the VP6 gene.
e. Contains the VP2, VP6 and VP7 genes.
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positive control.
RLP were recovered as follows: Yeast intracellular
extracts were ultracentrifuged over a 35% sucrose cush-
ion at 112,700 × g for 2 h at 4 C in a SW-28 rotor and
an Optima L-90K ultracentrifuge (Beckman Coulter,
Fullerton, CA, USA). The pellet obtained was resus-
pended in TNC buffer (50 mM Tris-HCl pH 8.0, 0.15
MN a C l ,1 0m MC a C l 2). Cesium chloride was added to
resuspended pellets to a concentration of 0.42 g/mL.
Sample was centrifuged at 148,930 × g for 18 h at 4°C
in a SW 55 Ti rotor (Beckman Coulter, Fullerton, CA,
USA). Opalescent bands were isolated and observed by
transmission electron microscopy (TEM). Samples were
visualized by negative staining: Twenty five microliters
of sample were fixed for 1 min in a 200 mesh grid
coated with formvar-carbon (Structure probe Inc., West
Chester, PA. USA). The grid was washed with ultrapure
water and stained with 3% uranyl acetate (Structure
probe Inc, West Chester, PA. USA), rinsed and left to
dry. Samples were observed in a transmission electron
microscope Jeol 1200EXII (Jeol, Peabody, MA. USA)
operated at 80 KV.
Cushion sucrose pellets and CsCl gradient bands were
also analyzed in sodium dodecyl sulfate (SDS)-12% poly-
acrylamide gels stained with Coomassie Brilliant Blue or
blotted onto a PVDF membrane (Immobilon-P, Milli-
pore, Billerica, MA, USA) in a wet chamber. Membranes
were blocked with PBS-5% non-fat dry milk and incu-
bated with a rabbit anti-rotavirus serum for 2 h at room
temperature. Membranes were washed twice with PBS-
0.1% non-fat dry milk and incubated with a peroxidase-
conjugated goat anti-rabbit IgG antibody (Jackson,
Immunoresearch laboratories, West Grove, PA, USA)
Figure 1 Plasmids constructed in this work.T h eΔVP2 gene was cloned under the PGK1 promoter and VP6 and VP7 genes were cloned
under individual TEF1 promoters. pWR26 was obtained by cloning the VP6 gene in plasmid pWRΔ2. The cassette TEF1-VP7-CYC1term was
amplified by PCR from pWR7 and cloned into pWR26 to obtain pWR267.
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three times with PBS-0.1% non-fat dry milk and peroxi-
dase activity was detected by reaction with the chemilu-
minescence substrate Western Lightning Plus ECL
(Perkin Elmer Inc, Waltman, MA USA). Gels and mem-
branes were scanned and analyzed using a ChemiDoc
system and the Image Lab 2.0 software (Biorad, Rich-
mond, CA, USA).
Results
Molecular strategies for the simultaneous expression of
three rotavirus genes
Plasmid and strain selection
tlRLP production requires the simultaneous presence in
each cell of three rotavirus proteins, VP2, VP6 and VP7,
which can be pursued by transforming cells with three
plasmids, each containing one gene and complementing
one auxotrophy, or by constructing a single plasmid
containing the three genes. In order to assess the best of
these two approaches, growth kinetics of two strains
were determined, one containing a single centromeric
plasmid expressing VP6 (W.T-6) and one containing
three empty plasmids (W.TLU-C): one centromeric sin-
g l ec o p yp l a s m i d( Y C p )a n dt w oe p i s o m a lh i g hc o p y
plasmids (YEp) (Table 1). Table 2 shows the maximum
specific growth rate and biomass yield on glucose of
both strains in batch culture. Three plasmids in the
same cell decreased the maximum specific growth rate
by 36%, compared with the strain with a single plasmid,
but it did not significantly influence biomass yield on
glucose. The W.TLU-C strain reached its maximum bio-
mass concentration 12 h later than the W.T-6 strain.
These results show that using three plasmids increased
the metabolic burden in auxotrophic yeast, probably due
to the need to complement three auxotrophies or to the
burden of producing multiple copies of each of the
three plasmids. A higher metabolic burden deviates car-
bon and nitrogen resources from heterologous protein
synthesis, and can be expected to result in lower recom-
binant protein yields. Thus, the use of three individual
plasmids was not adequate for the coexpression of three
proteins and was not further pursued. To reduce the
number of plasmids and auxotrophic markers used, a
second approach was devised, where one or three genes
were introduced in a single multi copy plasmid. The
constitutive promoters PGK1 and TEF1 were used (Fig-
ure 1 and Table 1). Genes cloned under these promoters
are expected to be constitutively expressed during the
whole culture, and expression levels should be indepen-
dent of the carbon or nitrogen sources used by the cell
[20].
To identify the best recombinant protein producers,
four different yeast strains and two different plasmid
variants (YCp and YEp) containing only the VP6 gene
were evaluated in batch cultures using CSM without
supplementation. Biomass and VP6 kinetics are shown
in Figure 2, while kinetic and stoichiometric parameters
are listed in Table 3. The strain with the highest growth
rate, PD.U-6 started growing before all strains and
reached the highest cell concentration. In contrast,
growth of the CEN.U-6 strain was delayed and the low-
est cell concentration was obtained. The PJ.T-6 strain
produced the highest VP6 concentration, which was 2.7
times higher than the VP6 concentration produced by
Table 2 Kinetic and stoichiometric parameters of strains
with one (W.T-6) or three (W.TLU-C) plasmids in the same
cell
Parameter Strain
W.T-6 W.TLU-C
μmax (h
-1) 0.250 ± 0.010 0.159 ± 0.011
TD (h) 2.77 ± 0.12 4.33 ± 0.30
Yx/s (g DCW/g glucose) 0.133 ± 0.001 0.147 ± 0.002
Culture time (h) 24 36
Figure 2 Batch cultures of S. cerevisiae strains producing VP6
in complete synthetic medium. A) Biomass concentration,
measured as dry cell weight and B) VP6 concentration, measured by
ELISA (see the analytical methods section). Mean values and
standard deviations of three individual cultures are shown.
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yield on glucose of strain PJ.T-6 were the highest
among the strains characterized. In general, VP6 pro-
duction was growth-associated, but VP6 concentration
decreased after glucose consumption in CEN.U-6 cul-
tures (data not shown), possibly as a result of a high
protease activity at the end of the culture. A similar
behavior has been reported during VLP production in
batch cultures after glucose depletion and before ethanol
consumption [23]. The lowest specific productivity was
observed in strain PD.U-6, while the lowest volumetric
productivity was obtained with strain CEN.U-6. Due to
the decrease in VP6 concentration observed in cultures
of strain CEN.U-6 after glucose depletion and its lower
volumetric productivity, strain CEN.U-6 was discarded
for the simultaneous production of the three rotavirus
proteins and fed batch culture improvements. No effect
of the plasmid variant used was observed, even when
YEp plasmids have up to 100 copies per cell [24].
Strains PJ.T-6 and PD.U-6 had the highest volumetric
productivities in batch cultures. Therefore, their parental
strains, PJ69-4a and PD 83B.1d, were used to construct
new strains with the multicopy plasmids pWR6 and
pWR267 capable of producing VP6 (strains PJ.U-6) and
VP2, VP6 and VP7 in the same cell (PD.U-267 and PJ.
U-267). These new strains were compared for their het-
erologous protein production capability in fed-batch cul-
ture conditions.
Process strategies for the simultaneous expression of
three rotavirus genes
Fed batch cultures
Fed batch cultures of PD.U-6, PD.U-267, PJ.U-6 and PJ.
U-267 strains were performed. Biomass concentration
and VP6 production were followed during cultures (Fig-
ure 3). Yields and productivities are illustrated in Figure
4. As observed in batch cultures, PJ strains grew slower
than PD strains before and after the fed-batch stage.
Accordingly, maximum biomass concentrations of the
PJ.U strains were 3.5 times lower than those of PD.U
strains. VP6 concentration before nutrient feeding was
less than 1 mg/mL in all strains. VP6 accumulated faster
during the feeding stage. Maximum VP6 concentrations
obtained ranged from 1 to 7 mg/L in strains PJ.U-6 and
PD.U-267, respectively. Interestingly, when VP6 was
produced alone, its concentration was three- to two-fold
lower than when it was co-expressed with VP2 and VP7
(Figure 4A), regardless of the strain used. YP/X was simi-
lar in strains PJ.U-6, PJ.U-267 and PD.U-6, but increased
more than three-fold in strain PD.U-267 (Figure 4B),
Table 3 Kinetic and stoichiometric parameters of batch cultures for VP6 producers
Parameter Strain
PJ.T-6 W.T-6 CEN.U-6 PD.U-6
μmax (h
-1) 0.259 ± 0.005 0.276 ± 0.019 0.251 ± 0.035 0.299 ± 0.019
VP6 (μg/L) 214 ± 21 154 ± 23 80 ± 1 181 ± 37
Yx/s (g DCW/g glucose) 0.107 ± 0.002 0.105 ± 0.002 0.088 ± 0.003 0.160 ± 0.001
Yp/x (μg VP6/g DCW) 99.42 ± 7.95 73.35 ± 9.61 45.47 ± 2.76 56.13 ± 11.46
Yp/s (μg VP6/g glucose) 10.68 ± 1.05 7.74 ± 1.16 4.02 ± 0.40 9.03 ± 1.88
Specific productivity (μg VP6/gDCW· h) 4.52 ± 0.36 2.82 ± 0.37 2.84 ± 0.17 2.14 ± 0.44
Volumetric productivity (μg VP6/L·h) 9.70 ± 0.95 5.96 ± 0.89 5.02 ± 0.50 6.88 ± 1.43
Figure 3 Fed batch cultures of S. cerevisiae strains producing
VP6 or VP2, VP6 and VP7. Complete synthetic medium
supplemented with leucine 1.8 mM, glutamate 20 mM and
succinate 50 mM was used. A) Biomass kinetics, measured as dry
cell weight, and B) VP6 production, measured by ELISA. Mean values
and standard deviations of three individual cultures are shown.
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logous protein production in this strain. Strain PD.U-
267 had the highest specific and volumetric productiv-
ities (Figures 4C and 4D).
Yeast extracts of PD.U-267 were submitted to a
sucrose cushion and isopycnic ultracentrifugation to
recover tlRLP. The presence of VP2, VP6 and VP7 in
different purification stages was detected by immuno-
blotting using monoclonal antibodies (Figure 5). CsCl
b a n d sw e r ea n a l y z e db yS D S - P A G Ea n dW e s t e r nB l o t
(Figure 6A and 6B), showing the presence of the three
rotavirus proteins. Densitometry of SDS-PAGE gels
revealed a relative mass ratio of the three recombinant
rotavirus proteins VP2:VP6:VP7 of 1:12:4 in samples
from gradients band. RLP were observed by TEM in the
bands recovered by ultracentrifugation (Figure 6C and
6D). tlRLP had a morphology similar to that previously
reported [25]. Measurements of the RLP obtained were
performed using the ImageJ software (Wayne Rasband,
NIH, USA), and correspond to the expected size (71 ± 5
n m )f o rR L P .T h ep r e s e n c eo ft h et h r e er e c o m b i n a n t
proteins in the preparations obtained after purification
by density gradients and TEM images confirm the suc-
cessful production of triple-layered RLP in yeast. Low
VP7 concentration in the purified bands could be
related to a lower quantity of protein produced or
inadequate aggregation conditions related to glycosila-
tion patterns and transport phenomena from the ER to
assemble into tlRLP.
Discussion
In this work, strategies for the production of triple-
layered VLP in yeast were implemented. Our first
attempts to express rotavirus VP6 in batch cultures
Figure 4 Product formation and productivities in fed batch cultures of S. cerevisiae strains. A) Maximum VP6 concentration, B) VP6 yields
on biomass, C) Specific productivities and D) Volumetric productivities. For details, refer to the Analytical Methods section. Mean values and
standard deviations of three individual cultures are shown.
Figure 5 Immunoblotting of proteins at different purification stages. A) Inactivated rotavirus strain SA-11 (positive control) B) Extract of a
culture of PD.U-C (negative control). C) Yeast extract of the PD.U-267 strain at the end of the fed batch culture. D) Pellet from a sucrose cushion
dissolved in TNC buffer. E) A CsCl gradient band. Samples were collected at the end of the fed batch culture and processed as described in the
Analytical Methods section. Three monoclonal antibodies were used, 3A8, 255 and IC3 for VP2, VP6 and VP7, respectively. All antibodies bind to
conformational epítopes. 200 μL of each sample were loaded onto nitrocellulose membranes.
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of magnitude lower than those routinely obtained in our
laboratory in the insect cell-baculovirus system, ca. 200
mg/L (unpublished results). High recombinant protein
concentration is especially important for the production
of VLP, as higher concentrations are expected to result
in higher assembly efficiency both in vivo and in vitro
methods [1]. Therefore, molecular and process strategies
for increasing the concentration of recombinant rota-
virus proteins in yeast were designed in this work to
allow their assembly into tlRLP. First, the use of three
individual plasmids was compared with the use of a sin-
gle plasmid. The use of three plasmids resulted in an
important metabolic burden, as evidenced by a decrease
in growth rate in comparison with the strain with a sin-
gle plasmid. Using a single plasmid for the expression of
the three rotavirus genes has several advantages: (a) the
copy number is the same for each rotavirus gene, (b)
the nucleic acid demand is reduced, and (c) only one
auxotrophy needs to be complemented. Several authors
have previously reported that the metabolic burden of
recombinant protein production in S. cerevisiae increase
due to plasmid copy number amplification [26-28].
Therefore, the use of a single plasmid expressing the
three rotavirus genes was pursued (see Figure 1). Inter-
estingly, no difference in growth rate was observed
when the same strain with a single plasmid expressed
one or three recombinant proteins (Figure 3A), suggest-
ing that the burden imposed by three plasmids was not
due to the simultaneous expression of three recombi-
nant genes, but to the load of plasmid amplification or
to the need of complementing three auxothropies.
To select the yeast strain and plasmid to be used for
the production of tlRLP, four Saccharomyces cerevisiae
laboratory strains with different auxotrophic markers
and two types of plasmids, YCp (low copy number) and
YEp (high copy number) containing only the rotavirus
VP6 gene, were evaluated. The CEN.PK. strains have
been used for the industrial production of metabolites
and some extracellular proteins in laboratory and com-
mercial applications [29]. CEN.PK.113-5D strain has
only one auxotrophy for Ura. The W303-1a is a widely
used laboratory haploid strain and has 5 auxotrophies
(see Table 1). The PD strain was obtained from the
Figure 6 Analysis of rotavirus-like particles obtained from cesium chloride gradients. A) and B) SDS-PAGE and Western blot analysis of
two opalescent bands isolated from yeast extracts of two different cultures (lanes 1 and 2). Yeast extract of the PD.U-C strain as negative control
(lane 3). Each lane was loaded with 5 μg of total protein. C) and D) Transmission electron micrographs of rotavirus-like particles recovered by
cesium chloride gradients. Samples were stained with 3% uranyl acetate. Magnification 150,000× and 250,000×, respectively.
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trophies, leaving only an auxotrophy for Ura. e PJ69-4a
was developed for the two-hybrid system and has four
auxotrophies. VP6 production was growth-associated in
all strain and plasmid combinations. The best VP6 pro-
ducers were the PJ.T-6 and the PD.U-6 strains (Table
3). While the PJ.T-6 strain has 5 auxothrophies, the PD.
U-6 has only one. All auxotrophies for the PJ.T-6 strain
were supplemented, with the exception of Ura. A
decrease in VP6 concentration after the onset of the sta-
tionary growth phase was observed only in cultures of
the CEN.U-6 strain, most likely a result of protease
activity. Although in this work no efforts were pursued
to identify the proteases involved, other studies have
reported a high aspartyl and serine protease activities
(PrA and PrB, mainly) in Saccharomyces strains expres-
sing a recombinant hepatitis B surface antigen (rHBsAg)
[23]. PrA and PrB are located in the vacuole and are
released to the extracellular space when cells rupture.
Their concentration increases in response to nutritional
stress, and results in important protein degradation
[30,31]. No effect of the type of plasmid used for the
individual expression of VP6 was observed. This beha-
vior could be related to a higher stability of centromeric
plasmids in comparison with plasmids based on 2 m
sequences, even when the later have higher copy num-
bers [24].
Selection of the best strain increased recombinant VP6
concentration one order of magnitude. However, VP6
concentration was still three orders of magnitude lower
than that obtained in insect cell cultures. Therefore,
efforts were aimed at increasing the recombinant pro-
tein concentration by using fed-batch cultures, and eval-
uating two strains that were the best producers in batch
cultures. Nutrient feeding increased VP6 concentration
11 times, when VP6 was expressed alone, and 28 times
when it was coexpressed with VP2 and VP7. VP6 con-
centration was three-fold higher when it was co-
expressed with VP2 and VP7. This behavior could be
associated with a synergistic stabilization of the three
structural proteins, protecting them from proteases by
their complex structure at the end of the fed batch cul-
t u r e .P J . Us t r a i n sg r e ws l o w er in fed batch cultures and
produced less recombinant protein than the PD.U
strains. This behavior could be associated to the number
of auxotrophies of the PJ.U strain and/or a non-opti-
mized feeding strategy. The maximum VP6 concentra-
tion obtained in fed-batch cultures was 144 times higher
than the first batch cultures without strain or plasmid
selection. The PD.U strains were also the most produc-
tive, with a productivity of 196 μg/L h.
The modifications of (a) supplementing limiting meta-
bolites and (b) using a single vector with all three genes
increased productivity in batch and fed batch cultures in
complete synthetic medium without sacrificing the
strong selection pressure that would be lost in complex
media. The higher cost associated with defined and sup-
plemented media may be justified on the basis of
increased reproducibility, productivity and regulatory
requirements for industrial purposes [32].
VLP formation in Saccharomyces cerevisiae was evi-
dent in transmission electron microscopy images. How-
ever, the VP7/VP6 ratio measured by densitometry in
SDS-PAGE gels was 59% lower than that present in the
triple-layered rotavirus particle (VP7 mass/VP6 mass =
0.83, calculated from the molecular weight of VP7 and
VP6). The observed rotavirus protein ratio in CsCl gra-
dients indicates that only 41% of the obtained rotavirus-
like particles were triple layered, as a result of an ineffi-
cient assembly or expression of VP7. Thus, a challenge
that must be overcome for rotavirus VLP expression in
yeast is increasing the heterologous protein concentra-
tion to promote a more efficient self-assembly into VLP.
In the case of recombinant VLP production in S. cerevi-
siae, limitations in accumulation of VLP can result from
(a) limitation of raw materials for the synthesis of the
different components of VLP, (b) protein degradation
processes, (c) inhibition of proper particle formation, (d)
physical constraints on volume in the cytosol, among
others. These factors may work in synergistic ways to
limit productivity, i.e. limitations in particle formation
may divert recombinant protein to degradation pro-
cesses. Volumetric productivities of rotavirus proteins in
this study are still one order of magnitude lower than
the values reached in insect cells [8]. As the culture
media, the production process and the equipment
required for recombinant protein production in yeast
systems are simpler and less expensive than those used
in the insect cell system, we believe that yeast are an
attractive option for tlRLP production.
In the present study, the simultaneous production of
three proteins aimed to the production of triple-layered
VLP is shown for the first time in yeast. Although,
tlRLP concentration was very low in comparison with
other expression platforms, this study constitutes the
basis for economic and easy large-scale production of
these complex proteins in an efficient system such as
yeast. These developments should be useful for the anti-
gen production in a recombinant veterinary vaccine for-
mulation, but can be extrapolated to human use, when
the process conditions and the economic costs asso-
ciated to downstream processes become competitive.
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